3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
4
Neoplasms
3
Prostatic Neoplasms
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Endometrial Neoplasms
2
Uterine Neoplasms
1
Sarcoma
1
Lung Neoplasms
1
Locally Advanced Cervical Cancer
1
Carcinoma
1
Breast Neoplasms
1
Adenocarcinoma
1
Interventions
Cisplatin
2
Carboplatin
2
durvalumab
1
Sodium Chloride
1
Paclitaxel
1
Brachytherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Locally Advanced Cervical Cancer
×
Brachytherapy
×
Clear all
NCT03830866
2024-07-26
CALLA
AstraZeneca
Phase 3
Completed
770 enrolled
12 charts